Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksGML
resources
GML

Galaxy Medicare Ltd.

NSE: GML
SME
Sector: Healthcare
17.70-0.8 (-4.32%)
24 Aug, 2:29 PM

Annual Reports and Financial Documents

No downloads available

Corporate Announcements and Regulatory Filings

Galaxy Medicare Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Reply to Clarification- Financial results22 Jul 2026
    The Exchange had sought clarification from Galaxy Medicare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
  2. Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter20 Jul 2026
    Galaxy Medicare Limited has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance Pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the Quarter Ended on 30th June, 2026.
  3. Certificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026
    Galaxy Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  4. Disclosure under SEBI Takeover Regulations22 Jun 2026
    Galaxy Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
  5. Appointment29 May 2026
    Galaxy Medicare Limited has informed the Exchange regarding the Re-Appointment of M/s Saroj Ray & Associates, Practicing Company Secretaries as Secretarial Auditor of the Company for the Financial Year 2026-2027 With Effect From May 29, 2026.
  6. Appointment29 May 2026
    Galaxy Medicare Limited has informed the Exchange regarding Re-Appointment of Mr. Aklant Das as Non- Executive Independent Director of the Company With Effect From 30th September 2026.
  7. Appointment29 May 2026
    Galaxy Medicare Limited has informed the Exchange regarding Re-Appointment of Mr. Soumya Mohanty as Non- Executive Independent Director of the Company With Effect From 30th September 2026.
  8. Appointment29 May 2026
    Galaxy Medicare Limited has informed the Exchange regarding Re-Appointment of Mr. Shaswat Kumar Rout as Non- Executive Independent Director of the Company With Effect From 24th April 2026.
  9. Appointment29 May 2026
    Galaxy Medicare Limited has informed the Exchange regarding Re-Appointment of Mr. Subhasish Das as Whole Time Director of the Company With Effect From 1st August 2026.
  10. Appointment29 May 2026
    Galaxy Medicare Limited has Informed the Exchange Regarding the Re-Appointment of Mr. Dillip Kumar Das as Managing Director of the Company With Effect From 1st July 2026.
  11. Dividend29 May 2026
    Galaxy Medicare Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 0.35 per equity share for the Financial Year 2025-2026,Subject to the Approval of Shareholders in the Annual General Meeting.
  12. Outcome of Board Meeting29 May 2026
    Galaxy Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  13. Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter14 Apr 2026
    Galaxy Medicare Limited has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance Pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the Quarter Ended on 31st March, 2026
  14. Structural Digital Database14 Apr 2026
    Galaxy Medicare Limited has Submitted the SDD Compliance Certificate for the Financial Year Ended on 31st March, 2026, Pursuant to Regulations 3(5) and 3(6) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
  15. Certificate under SEBI (Depositories and Participants) Regulations, 20187 Apr 2026
    Galaxy Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  16. Appointment28 Mar 2026
    Galaxy Medicare Limited has informed the Exchange regarding Appointment of M/s. Saroj Ray & Associates as Secretarial Auditor of the Company for the Financial Year 2025 - 2026 w.e.f. 28th March, 2026.
  17. Outcome of Board Meeting28 Mar 2026
    Galaxy Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on March 28, 2026.
  18. Trading Window27 Mar 2026
    Galaxy Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  19. Reply to Clarification- Financial results23 Feb 2026
    The Exchange had sought clarification from Galaxy Medicare Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
  20. Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter14 Jan 2026
    Galaxy Medicare Limited has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance Pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the Quarter Ended on 31st December 2025.

Frequently Asked Questions

Where can I download the annual report of Galaxy Medicare Ltd.?
Annual reports of Galaxy Medicare Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Galaxy Medicare Ltd.?
Quarterly earnings results and presentations of Galaxy Medicare Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Galaxy Medicare Ltd. publish earnings call transcripts?
Earnings call transcripts of Galaxy Medicare Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Galaxy Medicare Ltd.?
Investor presentations and annual day presentations of Galaxy Medicare Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Galaxy Medicare Ltd.?
Corporate announcements and regulatory filings of Galaxy Medicare Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Galaxy Medicare Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Galaxy Medicare Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Galaxy Medicare Ltd.?
The ISIN (International Securities Identification Number) of Galaxy Medicare Ltd. is INE09A801015. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Galaxy Medicare Ltd. listed?
Galaxy Medicare Ltd. is listed on NSE and BSE. The NSE symbol is GML and the BSE code is -.
Where can I find the shareholding pattern of Galaxy Medicare Ltd.?
The quarterly shareholding pattern of Galaxy Medicare Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Galaxy Medicare Ltd. on Sharpely?
Share price data for Galaxy Medicare Ltd. is updated as of 24 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.